Bruker Corp
BRKR
Market Cap$5.16B
Close$
$74.11
152.5% upside
Current Fair Value
152.5% upsideUndervalued by 152.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.16 Billion |
|---|---|
| Enterprise Value | $7.98 Billion |
| Dividend Yield | $0.20 (0.59%) |
| Earnings per Share | $0.76 |
| Beta | 1.16 |
| Outstanding Shares | 151,600,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 64.72 |
|---|---|
| PEG | - |
| Price to Sales | 1.33 |
| Price to Book Ratio | 2.45 |
| Enterprise Value to Revenue | 2.32 |
| Enterprise Value to EBIT | 92.11 |
| Enterprise Value to Net Income | 100 |
| Total Debt to Enterprise | 0.37 |
| Debt to Equity | 1.6 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bruker Corp
6,000 employees
CEO: Frank Laukien Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...